program-1 (Deciphera Pharmaceuticals)

N/A

Report date: 2025/01/26 17:32:50
NME

Base Information

Drug Nameprogram-1 (Deciphera Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 inhibitors
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeciphera Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesDeciphera Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A